Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Nov 26, 2014; 6(11): 1209-1217
Published online Nov 26, 2014. doi: 10.4330/wjc.v6.i11.1209
Published online Nov 26, 2014. doi: 10.4330/wjc.v6.i11.1209
Blood glucose management in the patient undergoing cardiac surgery: A review
Pingle Reddy, Brian Duggar, John Butterworth, Department of Anesthesiology, Virginia Commonwealth University, Richmond, VA 232298-0695, United States
Author contributions: All authors conceived of the project, wrote and edited the manuscript, and are responsible for the content.
Correspondence to: John Butterworth, IV, MD, Professor and Chair of Anesthesiology, Department of Anesthesiology, Virginia Commonwealth University, PO Box 980695, Richmond, VA 232298-0695, United States. jbutterworth@mcvh-vcu.edu
Telephone: +1-804-8289160 Fax: +1-804-8288300
Received: December 28, 2013
Revised: August 27, 2014
Accepted: September 16, 2014
Published online: November 26, 2014
Revised: August 27, 2014
Accepted: September 16, 2014
Published online: November 26, 2014
Core Tip
Core tip: There is a growing body of evidence that moderate glycemic control (e.g., 120-180 mg/dL, 6.7-10.0 mmol/L) is an appropriate goal in cardiac surgery. Achieving this goal can be accomplished by adopting a multidisciplinary approach, addressing the entire continuum of care, demanding a short project timeline, and identifying gaps in current management.